Eddit

Version vom 1. Juni 2020, 16:59 Uhr

• Further reading

32251543 2020. The COVID-19 (Coronavirus) pandemic: reflections on the roles of librarians and information professionals
32379021 2020. Rapid Publication, Knowledge Sharing, and Our Responsibility During the COVID-19 Pandemic

• Unproven ideas

• Reviews on covid19 disease

32379112 2020. Novel Coronavirus COVID-19: Current Evidence and Evolving Strategies
32348588 2020. COVID-19 diagnosis and management: a comprehensive review
32232980 ä. COVID?19 epidemic: Disease characteristics in children

• Clinical guidelines and advice

32359076 2020. COVID-19: Use of the Clinical Frailty Scale for Critical Care Decisions

• Respiration mgmt

32249028 2020. The "helmet bundle" in COVID-19 patients undergoing non invasive ventilation
32268933 2020. Home PAP devices in COVID-19 infected patients

• Diagnosis (Laboratory)

32329102 2020. Application of a portable instrument for rapid and reliable detection of SARS-CoV-2 infection in any environment
32295895 2020. Comparison of Copan ESwab and FLOQSwab for COVID-19 Diagnosis: Working around a Supply Shortage
32380382 ä. Detection of low levels of SARS-CoV-2 RNA from nasopharyngeal swabs using three commercial molecular assays

32329138 2020. Who should perform the rhinopharyngeal swab in COVID-19 positive patients?
32356761 2020. Navigating the Pandemic Response Life Cycle: Molecular Diagnostics and Immunoassays in the Context of COVID-19 Management

32349033 2020. Novel biosensor platforms for the detection of coronavirus infection and SARS-CoV-2
32366669 2020. Multicenter Evaluation of the Cepheid Xpert Xpress SARS-CoV-2 Test
32229605 2020. Evaluation of Nucleocapsid and Spike Protein-Based Enzyme-Linked Immunosorbent Assays for Detecting Antibodies against SARS-CoV-2

• Diagnosis (Lung CT, Sonography)

32217900 2020. High-Resolution Computed Tomography Manifestations of 5 Pediatric Patients With 2019 Novel Coronavirus
32349032 2020. Use of Radiographic Features in COVID-19 Diagnosis: Challenges and Perspectives

• Diagnosis (other modalities)

• Structure of covid19

32169673 2020. Genetic evolution analysis of 2019 novel coronavirus and coronavirus from other species
32349035 2020. Genomic Analysis and Comparative Multiple Sequence of SARS-CoV2

• Target binding and uptake

32376714 2020. Gene of the month: the 2019-nCoV/SARS-CoV-2 novel coronavirus spike protein

• Cytopathic effects

• Secretion and shedding

• Innate sensing

• Immunology

32379887 ä. T cell subset counts in peripheral blood can be used as discriminatory biomarkers for diagnosis and severity prediction of COVID-19

• Cytokine storm, hemophagocytic lymphohistiocytosis, macrophage activation syndrome

• Pathobiology

32364407 2020. COVID-19 Lung Injury Is Different From High Altitude Pulmonary Edema (Re: High Alt Med Biol Epub ahead of print ; DOI: 10 1089/ham 2020 0055)
32281877 2020. COVID-19 Lung Injury is Not High Altitude Pulmonary Edema
32374419 2020. Pulmonary Pathology of Early Phase COVID-19 Pneumonia in a Patient with a Benign Lung Lesion

32198191 2020. Autopsy in suspected COVID-19 cases
32358895 2020. Histological pattern in Covid-19 induced viral rash

• Disease Models

• Similar diseases and pathomechanisms

32319148 2020. COVID-19: searching for clues among other respiratory viruses

• Early symptoms

• Systemic disease, any manifestations
• Co-Infection

• ARDS

• Pulmonary embolism, coagulation

32311843 2020. Thromboembolic events and apparent heparin resistance in patients infected with SARS-CoV-2

• Hematology

• Heart

32354798 2020. Acute myocardial injury is common in patients with covid-19 and impairs their prognosis
32282502 ä. Cardiovascular Considerations in Treating Patients With Coronavirus Disease 2019 (COVID-19)
32306491 2020. Cardiac involvement in COVID-19 patients: Risk factors, predictors, and complications: A review
32270559 2020. Cardiac and arrhythmic complications in patients with COVID-19
32232979 ä. Analysis of heart injury laboratory parameters in 273 COVID?19 patients in one hospital in Wuhan, China

• Neurology, ophthalmology, orl

32342566 2020. Objective evaluation of anosmia and ageusia in COVID-19 patients: Single-center experience on 72 cases
32317428 2020. What ophthalmologists should know about conjunctivitis in the COVID-19 pandemic?
32366336 2020. Olfactory and gustatory dysfunction caused by SARS-CoV-2: comparison with cases of infection with influenza and other viruses
32342636 2020. Potential pathogenesis of ageusia and anosmia in COVID-19 patients
32329222 2020. Self-reported olfactory loss associates with outpatient clinical course in Covid-19
32301284 2020. Smell dysfunction: a biomarker for COVID-19

• Dermatology

32380219 ä. Chilblains are a common cutaneous finding during the COVID-19 pandemic: a retrospective nationwide study from France
32380215 ä. Reply to ?Varicella-like exanthem as a specific COVID-19-associated skin manifestation: multicenter case series of 22 patients?: discussing specificity
32358979 2020. Diffuse cutaneous manifestation in a new mother with COVID-19 (SARS-Cov-2)
32329897 2020. Chilblain-like lesions on feet and hands during the COVID-19 Pandemic
32366113 2020. Foot Manifestations in a COVID-19 Positive Patient: A Case Study
32310671 2020. Addressing the Question of Dermatologic Manifestations of SARS-CoV-2 Infection in the Lower Extremities: A Closer Look at the Available Data and its Implications
32365277 2020. New emerging dermatological symptoms in coronavirus pandemic
32301221 2020. A preliminary observation: Male pattern hair loss among hospitalized COVID-19 patients in Spain - A potential clue to the role of androgens in COVID-19 severity
32363963 2020. Mucous membrane pemphigoid and COVID-19 treated with high-dose intravenous immunoglobulins: a case report

32378743 2020. Acro-ischemia in hospitalized COVID-19 patients
32359182 2020. Occurrence of SARS-CoV-2 during mycophenolate mofetil treatment for pemphigus
32359180 2020. Pityriasis rosea as a cutaneous manifestation of COVID-19 infection

32215952 2020. Cutaneous manifestations in COVID-19: a first perspective

32330340 2020. Cutaneous manifestations in COVID-19: the experiences of Barcelona and Rome
32330339 2020. Cutaneous manifestation of COVID-19 in images: a case report
32330336 2020. SARS-CoV-2 infection presenting as a febrile rash
32330334 2020. Chilblain-like lesions during COVID-19 epidemic: a preliminary study on 63 patients
32330324 2020. Acral cutaneous lesions in the time of COVID-19
32330322 2020. Did Whatsapp((R)) reveal a new cutaneous COVID-19 manifestation?
32329915 2020. Acute urticaria with pyrexia as the first manifestations of a COVID-19 infection
32294273 2020. Urticarial eruption in COVID-19 infection
32294271 2020. COVID-19 and Cutaneous manifestations
32294270 2020. Viral exanthem in COVID-19, a clinical enigma with biological significance
32294264 2020. Cutaneous manifestations in COVID-19: a new contribution
32294259 2020. A distinctive skin rash associated with Coronavirus Disease 2019 ?

• Gastroenterology, hepatology

32241899 2020. Gastrointestinal symptoms of 95 cases with SARS-CoV-2 infection
32139552 2020. SARS-CoV-2 induced diarrhoea as onset symptom in patient with COVID-19
32327526 2020. Severe liver failure during SARS-CoV-2 infection
32279064 2020. Coronavirus Disease (COVID-19) and the Gastrointestinal System in Children
32267098 2020. Digestive system involvement of novel coronavirus infection: Prevention and control infection from a gastroenterology perspective
32215956 2020. Covid-19 and the digestive system

• Kidney, urology

32366514 2020. Acute Kidney Injury in COVID-19: Emerging Evidence of a Distinct Pathophysiology
32345702 2020. Renal Involvement and Early Prognosis in Patients with COVID-19 Pneumonia

• Risk and special populations

32376422 ä. Cyclosporine therapy during the COVID-19 pandemic is not a reason for concern
32380214 ä. Clinical considerations for managing dermatology patients on systemic immunosuppressive and/or biologic therapy during COVID-19 pandemic
32245909 2020. A fatal case of COVID-19 pneumonia occurring in a patient with severe acute ulcerative colitis
32312788 2020. Covid-19 infection in Crohn s disease under treatment with adalimumab
32307955 2020. COVID-19, THE KIDNEY AND HYPERTENSION
32220017 2020. Perioperative Presentation of COVID-19 Disease in a Liver Transplant Recipient
32340044 2020. The ACE-2 in COVID-19: Foe or Friend?
32208987 2020. Renin-angiotensin system (RAS) blockers and the COVID-19 pandemic: at present there is no evidence to abandon RAS blockers
32367746 2020. ACE2, COVID-19, and ACE Inhibitor and ARB Use during the Pandemic: The Pediatric Perspective
32348166 2020. Effects Of ARBs And ACEIs On Virus Infection, Inflammatory Status And Clinical Outcomes In COVID-19 Patients With Hypertension: A Single Center Retrospective Study
32324897 2020. Management of the first patient with confirmed COVID-19 in pregnancy in India: From guidelines to frontlines
32330287 2020. A systematic scoping review of COVID-19 during pregnancy and childbirth
32270479 2020. Radiological findings and clinical characteristics of pregnant women with COVID-19 pneumonia
32271947 2020. Delivery in pregnant women infected with SARS-CoV-2: A fast review
32369616 2020. Critically ill pregnant patient with COVID-19 and neonatal death within two hours of birth
32310015 2020. Cerebrovascular disease is associated with an increased disease severity in patients with Coronavirus Disease 2019 (COVID-19): A pooled analysis of published literature
32255507 2020. COVID-19 and Older Adults: What We Know
32301766 ä. Cardiovascular Pharmacology in the Time of COVID-19: A Focus on Angiotensin-Converting Enzyme 2
32376098 ä. A MULTINATIONAL REPORT TO CHARACTERISE SARS-CoV-2 INFECTION IN PEOPLE WITH CYSTIC FIBROSIS
32371817 2020. Angiotensin-converting enzyme-2 in SARS-CoV-2 infection: good or bad?
32371814 2020. Response to four comments on ?Can angiotensin receptor-blocking drugs perhaps be harmful in the COVID-19 pandemic??
32371812 2020. COVID-19, hypertension and angiotensin receptor-blocking drugs
32371810 2020. Comment on ?Can angiotensin receptor-blocking drugs perhaps be harmful in the COVID-19 pandemic??
32345701 2020. The Immunocompromised Transplant Recipient and SARS-CoV-2 Infection
32317402 2020. Early Description of Coronavirus 2019 Disease in Kidney Transplant Recipients in New York
32312797 2020. COVID-19 and Calcineurin Inhibitors: Should They Get Left Out in the Storm?
32253888 2020. Coronavirus COV-19/SARS-CoV-2 affects women less than men: clinical response to viral infection
32351121 2020. Evidence for Use or Disuse of Renin-Angiotensin System Modulators in Patients Having COVID-19 With an Underlying Cardiorenal Disorder
32353193 2020. Is the type of diabetes treatment relevant to outcome of COVID-19?
32162476 2020. Diabetes and COVID-19
32379925 2020. Improvement of SARS-CoV2 symptoms following Guselkumab injection in a psoriatic patient
32379913 2020. Evolution of COVID-19 infection in 4 psoriatic patients treated with biological drugs
32358791 2020. SARS-CoV-2 infection in a psoriatic patient treated with IL-17 inhibitor
32330323 2020. Safety of dupilumab in severe atopic dermatitis and infection of Covid-19: two case reports
32294258 2020. SARS-CoV-2 infection in a psoriatic patient treated with IL-23 inhibitor
32195824 2020. Can angiotensin receptor-blocking drugs perhaps be harmful in the COVID-19 pandemic?
32242993 2020. Familial hypercholesterolaemia and COVID-19: triggering of increased sustained cardiovascular risk
32354293 2020. Coronavirus disease 2019 (COVID-19) and pregnancy: a systematic review

• The morbid survivor
• Case reports

32343395 2020. Typically Atypical: COVID-19 Presenting as a Fall in an Older Adult

• Case series

32352202 2020. Clinical and Epidemiological Characteristics of 1,420 European Patients with mild-to-moderate Coronavirus Disease 2019

• Registries

• Trials

• Candidate Compounds Covid19

32298218 2020. Potential for developing a SARS-CoV receptor-binding domain (RBD) recombinant protein as a heterologous human vaccine against coronavirus infectious disease (COVID)-19
32317431 2020. Therapeutic opportunities to manage COVID-19/SARS-CoV-2 infection: Present and future
32370727 2020. SARS-CoV-2 & Covid-19: Key-Roles of the Renin-Angiotensin System / Vitamin D Impacting Drug and Vaccine Developments

32338559 2020. Low dose radiation therapy for COVID-19 pneumonia: is there any supportive evidence?
32319538 2020. Zinc and respiratory tract infections: Perspectives for COVID19 (Review)
32310190 2020. Coronavirus drugs: Using plasma from recovered patients as a treatment for COVID-19
32347747 2020. Can melatonin reduce the severity of COVID-19 pandemic?
32268052 2020. Vitamin D, Covid-19 and Children
32268051 2020. Optimisation of Vitamin D Status for Enhanced Immuno-protection Against Covid-19
32338164 2020. SARS-CoV-2 RNA dependent RNA polymerase (RdRp) targeting: an in silico perspective
32306860 2020. Moroccan Medicinal plants as inhibitors against SARS-CoV-2 main protease: Computational investigations
32306822 2020. Peptide-like and small-molecule inhibitors against Covid-19
32340551 2020. Natural products may interfere with SARS-CoV-2 attachment to the host cell
32329419 2020. Andrographolide as a potential inhibitor of SARS-CoV-2 main protease: an in silico approach
32329408 2020. Discovery of potential multi-target-directed ligands by targeting host-specific SARS-CoV-2 structurally conserved main protease
32362235 2020. Understanding the binding affinity of noscapines with protease of SARS-CoV-2 for COVID-19 using MD simulations at different temperatures
32362243 2020. Identification of new anti-nCoV drug chemical compounds from Indian spices exploiting SARS-CoV-2 main protease as target
32364041 2020. Using integrated computational approaches to identify safe and rapid treatment for SARS-CoV-2
32364011 2020. FDA-approved thiol-reacting drugs that potentially bind into the SARS-CoV-2 main protease, essential for viral replication
32362217 2020. In silico study the inhibition of angiotensin converting enzyme 2 receptor of COVID-19 by Ammoides verticillata components harvested from Western Algeria
32362245 2020. An investigation into the identification of potential inhibitors of SARS-CoV-2 main protease using molecular docking study
32345124 2020. An in-silico evaluation of different Saikosaponins for their potency against SARS-CoV-2 using NSP15 and fusion spike glycoprotein as targets
32340562 2020. A molecular modeling approach to identify effective antiviral phytochemicals against the main protease of SARS-CoV-2
32376368 ä. Identifying potential treatments of COVID-19 from Traditional Chinese Medicine (TCM) by using a data-driven approach
32228825 2020. How to reduce the likelihood of coronavirus-19 (CoV-19 or SARS-CoV-2) infection and lung inflammation mediated by IL-1
32171193 2020. Induction of pro-inflammatory cytokines (IL-1 and IL-6) and lung inflammation by Coronavirus-19 (COVI-19 or SARS-CoV-2): anti-inflammatory strategies
32367767 2020. Potential inhibitors of coronavirus 3-chymotrypsin-like protease (3CL(pro)): an in silico screening of alkaloids and terpenoids from African medicinal plants
32238094 2020. Identification of chymotrypsin-like protease inhibitors of SARS-CoV-2 via integrated computational approach
32345140 2020. Stilbene-based natural compounds as promising drug candidates against COVID-19
32266867 2020. In-silico homology assisted identification of inhibitor of RNA binding against 2019-nCoV N-protein (N terminal domain)
32248766 2020. Computational studies of drug repurposing and synergism of lopinavir, oseltamivir and ritonavir binding with SARS-CoV-2 protease against COVID-19
32349031 2020. Role of Dipeptidyl Peptidase 4 Inhibitors in Diabetic Patients with Coronavirus-19 Infection
32173110 2020. A systematic review on the efficacy and safety of chloroquine for the treatment of COVID-19
32379348 2020. 3CL hydrolase-based multiepitope peptide vaccine against SARS-CoV-2 using immunoinformatics

• Other routes of infection

32271653 2020. Salivary Glands: Potential Reservoirs for COVID-19 Asymptomatic Infection
32379909 2020. SARS-CoV-2 possible contamination of genital area: implications for sexual and vertical transmission routes

• Biophysics of aerosols

• Passive protective equipment

32246972 2020. Ultraviolet germicidal irradiation: Possible method for respirator disinfection to facilitate reuse during the COVID-19 pandemic
32319881 2020. May hydrogen peroxide reduce the hospitalization rate and complications of SARS-CoV-2 infection?
32299521 2020. Environmental cleaning is effective for the eradication of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in contaminated hospital rooms: A patient from the Diamond Princess cruise ship
32337516 2020. Use of free CAD design software for 3D printing individualized face masks based on face scans
32379379 2020. Treatment of nasal bridge ulceration related to protective measures for the COVID-19 epidemic
32377058 ä. Sustainability of Coronavirus on different surfaces
32167245 ä. Effectiveness of N95 respirators versus surgical masks against influenza: A systematic review and meta?analysis
32362062 2020. Occupational skin conditions on the frontline: A survey among 484 Chinese healthcare professionals caring for Covid-19 patients
32302444 2020. Skin Reactions to Non-glove Personal Protective Equipment: An Emerging Issue in the COVID-19 Pandemic
32302449 2020. Covid-19: countermeasure for N95 mask-induced pressure sore

• Running your hospital

32358855 2020. Tracheostomy during COVID-19 pandemic-Novel approach
32298034 2020. How to avoid nosocomial spread during tracheostomy for COVID-19 patients
32270574 2020. Improving staff safety during tracheostomy in COVID-19 patients
32348600 2020. Bronchoscopy, laryngoscopy, and esophagoscopy during the COVID-19 pandemic
32348582 2020. Clinical trials during COVID-19
32365278 2020. Management of COVID-19 in hemodialysis patients: The Genoa experience
32321619 2020. How we mitigate and contain COVID-19 outbreak in hemodialysis center (HD): lessons and experiences
32350871 2020. Analysis of vaginal delivery outcomes among pregnant women in Wuhan, China during the COVID-19 pandemic
32196655 2020. Expert consensus for managing pregnant women and neonates born to mothers with suspected or confirmed novel coronavirus (COVID-19) infection
32362244 2020. Management of acute ischemic stroke in patients with COVID-19 infection: Report of an international panel
32345922 ä. Single-use Bronchoscopes: Applications in COVID-19 Pandemic
32300070 2020. Counterpoint: Twice-Weekly Hemodialysis Should Be an Approach of Last Resort Even in Times of Dialysis Unit Stress
32300069 2020. Twice-Weekly Hemodialysis Is an Option for Many Patients in Times of Dialysis Unit Stress
32267782 2020. Challenges Faced by Medical Journals During the COVID-19 Pandemic
32343162 2020. Conducting clinical trials during the COVID-19 pandemic
32280138 2020. Perfusion?s Role in Responding to the COVID-19 Pandemic
32372533 2020. Fecal testing for SARS-CoV-2 in patients undergoing elective lower gastrointestinal endoscopy is advised

• Mental aspects of health professionals

• Socio-psychiatric aspects of the status hygienicus

• Avoiding clinical medicine in other diseases

• Occupational medicine, workplace security and status hygienicus
• Economic aspects of the status hygienicus

• Educational aspects of the status hygienicus

• Host, vector, one health, atmospheric aspects

• Origin of Covid19
• Epidemiology

32325535 2020. Covid-19 in Fluchtlingsunterkunften: OGD jetzt weiter starken
32338071 2020. Racial Capitalism: A Fundamental Cause of Novel Coronavirus (COVID-19) Pandemic Inequities in the United States

32301199 2020. Estimation of basic reproduction number for COVID-19 and the reasons for its differences
32141624 ä. Transmission dynamics of the COVID?19 outbreak and effectiveness of government interventions: A data?driven analysis
32134116 ä. Unique epidemiological and clinical features of the emerging 2019 novel coronavirus pneumonia (COVID?19) implicate special control measures

• Remission, recurrence and persistence

• Failure of executive measures

• Failure of politics and public health guidance

32352911 2020. COVID-19 reveals weak health systems by design: Why we must re-make global health in this historic moment

• Political abuse of Covid19

• Lost people

32317499 2020. A tribute to frontline corona warriors--Doctors who sacrificed their life while saving patients during the ongoing COVID-19 pandemic

• Lost civilization

• History of covid19 exploration

• misc.

32377057 ä. Emerging technologies to combat COVID-19 pandemic
32323591 2020. Immunomodulators and immunosuppressants in the era of SARS-CoV-2 - could laboratory tests be the missing link?
32255383 2020. Biological treatment use amid the COVID-19 era, a close look at the unresolved perplexity

• Research tools

32339250 2020. A potential ex vivo infection model of human induced pluripotent stem cell-3D organoids beyond coronavirus disease 2019

• PrePrint scene
• from the ads
• Current state of coviki.org
• on-topic personal thoughts

32338071 2020. Racial Capitalism: A Fundamental Cause of Novel Coronavirus (COVID-19) Pandemic Inequities in the United States